Technion - Israel Institute of Technology
VC Fund
Haifa, Israel
Technion - Israel Institute of Technology is a VC fund in Haifa focused on Medical and Health Care. “Technikum” - the original German name of the Technion - is a tale of the century. The second industrial revolution created the printing presses and communications infrastructure allowing Jews scattered across the globe to organize in face of rising anti-Semitism. As Jews were often barred from technical education, the establishment of a technicalschool was a first priority to rebuilding a Jewish homeland. The Technion was to become unique worldwide as a university that would precede, create, shape, and protect a modern state.The cornerstone laid on April 11, 1912, set in motion a century of progress responding to national and global needs. Technion would grow rapidly, becoming a global pioneer in fields such as biotechnology, stem cells, space, computer science, nanotechnology, and energy. Three Technion professors have won Nobel Prizes. As it celebrates its cornerstone centennial in 2012, Technion City is a thriving world center of research and teaching, with 12,850 students and 80 graduate programs trailblazing excellence in research and teaching for the benefit of humanity.
- Total investments:
- 5
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Technion - Israel Institute of Technology invests in
Stages Technion - Israel Institute of Technology invests in
Countries Technion - Israel Institute of Technology invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $2.2M–$20M
Investment Focus
Industry
- Medical 3 (60%)
- Health Care 3 (60%)
- Therapeutics 2 (40%)
- Biotechnology 2 (40%)
- Drones 1 (20%)
Stage
- Seed 3 (60%)
- Series B 1 (20%)
- Venture - Series Unknown 1 (20%)
Country
- Israel 4 (80%)
- United States 1 (20%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Albert Einstein
Founder
|
Founder | Total investments: 0 | Find email | |
Amichai Shulman
Adjunct Teacher
|
Adjunct Teacher | Total investments: 6 | Find email | |
Carmel Rotschild
Senior Lecturer
|
Senior Lecturer | Total investments: 0 | Find email | |
|
Eyal S. Ron
Mentor
|
Mentor | Total investments: 0 | Find email | |
Guy Yachdav
Lecturer on Machine Learning
|
Lecturer on Machine Learning | Total investments: 0 | Find email | |
| See all 15 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Levron Medical
|
Levron Medical develops a novel autonomic integrated diagnostic and therapeutic device used to treat heart failure patients. | $2.2M / Seed / Nov 24, 2025 | |
Mana.bio
|
Mana.bio develops artificial intelligence–based platforms for drug delivery using lipid nanoparticles (LNPs). The company combines machine learning with nanotechnology to design, test, and refine LNP formulations through computational modeling and laboratory validation. Its technology focuses on extrahepatic tissue targeting and includes researchon lung-targeted delivery and safety improvements through predictive modeling. Mana.bio has introduced ChatLNP, a tool that supports literature analysis, property prediction, and formulation optimization. The platform integrates experimental results with public data to enhance model accuracy and broaden its design capabilities for gene therapy and RNA-based medicines. | $19.5M / Seed / Oct 10, 2023 | |
ViAqua Therapeutics
|
ViAqua Therapeutics Ltd develops drugs and therapeutics for aquaculture. The company was founded in 2014 and is based in Israel.ViAqua Therapeutics is developing the first orally administered treatment for aquaculture.The Company’s management bring a broad range of business development, technology development, management, and industrial biotechexperience. | $4.3M / Venture - Series Unknown / Jun 09, 2021 | |
Lydus Medical
|
Lydus Medical is a start-up company that develops a set of tools for anastomosis of small blood vessels. The company was founded in 2017 and is headquartered in Kfar Saba, Israel. | $2.7M / Seed / May 24, 2021 | |
Regulus Cyber
|
Regulus provides affordable GNSS spoofing detection and protection to the mass markets requiring reliability and low-cost. The Pyramid Software technology defends against ever-increasing attacks and interferences.The Regulus Pyramid GNSS technology provides revolutionary tools to defend against GNSS/GPS spoofing attacks for automotive,mobile, maritime, aviation, critical infrastructure and various other applications, markets and users. *(GNSS = Global Navigation Satellite Systems: GPS, BeiDou, Galileo, Glonass, and more.) | $4M / Series B / May 18, 2020 |
Co-Investors
S2G Investments
2 deals together
Agriline
1 deal together
Alon Medtech Ventures
1 deal together
Andreessen Horowitz
1 deal together
b2venture
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Technion - Israel Institute of Technology invest in?
Technion - Israel Institute of Technology invests primarily in Medical, Health Care and Therapeutics startups, most often at Seed and Series B stage. Most of the 5 investments tracked by Shizune back companies in Israel. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Technion - Israel Institute of Technology's check size?
Technion - Israel Institute of Technology typically joins rounds of $2.2M–$20M at Seed. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Technion - Israel Institute of Technology participates in.
How do I contact Technion - Israel Institute of Technology?
Public channels for Technion - Israel Institute of Technology include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Technion - Israel Institute of Technology?
The team at Technion - Israel Institute of Technology includes Albert Einstein (Founder), Amichai Shulman (Adjunct Teacher) and Carmel Rotschild (Senior Lecturer), among 15 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
